Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

750 to 774 of 896 results

Biotech deal-making off to a strong start in 2012, says Burrill

02-02-2012

Swiss drug major Roche's hostile $5.7 billion bid for the tools and sequencing systems company Illumina…

BiotechnologyFinancialLicensingMergers & AcquisitionsNorth America

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

Amgen to acquire US/German biotech firm

27-01-2012

Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based Amgen (Nasdaq:…

AmgenBiotechnologyMergers & AcquisitionsMicrometOncology

Celgene to buy Avila; posts strong 4th-qtr results

27-01-2012

USA-based Celgene (Nasdaq: CELG) yesterday revealed that it has entered into a definitive merger deal…

Avila TherapeuticsBiotechnologyCelgeneFinancialMergers & AcquisitionsOncologyPharmaceutical

Illumina implements “poison pill” with regard to Roche bid

27-01-2012

Responding to Swiss drug major Roche’s (ROG: SIX) hostile takeover over offer of $44.50 per share…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Global biotechnology market set to exceed $320 billion by 2015, says GIA

25-01-2012

The biotechnology industry was adversely affected by the global financial crisis, with several leading…

BiotechnologyGlobalMarkets & MarketingMergers & AcquisitionsResearch

Roche makes $5.7 billion hostile bid for Illumina

25-01-2012

Swiss drugs and diagnostic major Roche (ROG: SIX) announced this morning that it is proposing to acquire…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

OPKO Health to acquire Chilean drugmaker; buys cancer tests

24-01-2012

Florida, USA-based OPKO Health (NYSE: OPK) had a busy day yesterday, entering into a definitive agreement…

ALS DistribuidoraEuropeMergers & AcquisitionsOPKO HealthPharmaceuticalSouth America

XOMA acquires US rights to perindopril franchise

18-01-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has acquired US rights to the perindopril franchise…

AceonCardio-vascularMergers & AcquisitionsperindoprilPharmaceuticalServierXOMA Corp

Roche in epigenetics drug discovery collaboration

18-01-2012

USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

Pharma M&A in 2011 surges back to pre-recession levels

18-01-2012

As the global pharmaceutical industry faces a third (35%) of its 20 best-selling prescription medicines’…

LicensingMergers & AcquisitionsPharmaceutical

India’s Dishman buys French company

17-01-2012

Indian drugmaker Dishman Pharmaceuticals and Chemicals says that its Swiss unit has acquired a contract…

CréapharmGenericsMergers & Acquisitions

Valeant ups its bid for ISTA Pharma

17-01-2012

California, USA-based ophthalmology and allergy drug company ISTA Pharmaceuticals (Nasdaq: ISTA) says…

ISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalRespiratory and PulmonaryValeant Pharmaceuticals

Merck & Co out to lead in hepatitis C

12-01-2012

US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company’s…

Anti-viralsMerck & CoMergers & AcquisitionsPharmaceuticalResearch

2011 a bumper year for Pharma, Biotech and Generics M&A

11-01-2012

Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011

11-01-2012

Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

Shire gets US Rights to Resolor

10-01-2012

Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

Ownership change for BioLigands ApS

09-01-2012

The founding shareholders in BioLigands ApS together with UK based biotech Bridge BioResearch have taken…

BioLigandsMergers & AcquisitionsPharmaceutical

750 to 774 of 896 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top